Stockscreener 앱 받기
86.47
0.59%
0.51
시장 영업 전:
86.44
-0.03
-0.03%
전일 마감가:
$85.96
열려 있는:
$86.08
하루 거래량:
7.27M
Relative Volume:
1.45
시가총액:
$49.79B
수익:
$6.30B
순이익/손실:
$1.07B
주가수익비율:
46.98
EPS:
1.8406
순현금흐름:
$1.09B
1주 성능:
+0.80%
1개월 성능:
+6.46%
6개월 성능:
-0.23%
1년 성능:
+11.24%
1일 변동 폭
$85.83
$88.02
1주일 범위
$85.52
$88.28
52주 변동 폭
$72.30
$88.28
에드워즈라이프사이언시스 Stock (EW) Company Profile
명칭
Edwards Lifesciences Corp
전화
(949) 250-2500
주소
ONE EDWARDS WAY, IRVINE, CA
Compare EW vs ABT, SYK, MDT, BSX
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
에드워즈라이프사이언시스 Stock (EW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-01 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2026-01-09 | 업그레이드 | TD Cowen | Hold → Buy |
| 2025-12-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-11-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-10-29 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2025-10-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-10-07 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-29 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-04-24 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | 업그레이드 | Stifel | Hold → Buy |
| 2025-01-16 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-11 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-09-18 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-07-31 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-07-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-07-25 | 다운그레이드 | Truist | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-05-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-03-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-02-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-11-28 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-03-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | 다운그레이드 | Bernstein | Outperform → Underperform |
| 2023-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-10-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-10-26 | 개시 | Mizuho | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-29 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-03-16 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-27 | 재확인 | Citigroup | Buy |
| 2022-01-27 | 재확인 | Evercore ISI | Outperform |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | Stifel | Buy |
| 2022-01-27 | 재확인 | UBS | Neutral |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | 재확인 | Canaccord Genuity | Buy |
| 2021-07-30 | 재확인 | Deutsche Bank | Hold |
| 2021-07-30 | 재확인 | Jefferies | Buy |
| 2021-07-30 | 재확인 | Morgan Stanley | Overweight |
| 2021-07-30 | 재확인 | Oppenheimer | Outperform |
| 2021-07-30 | 재확인 | Stifel | Buy |
| 2021-07-30 | 재확인 | UBS | Neutral |
| 2021-07-30 | 재확인 | Wells Fargo | Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-04-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-11 | 재확인 | Canaccord Genuity | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Underperform |
| 2020-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-10 | 개시 | Oppenheimer | Outperform |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-10-24 | 재확인 | Canaccord Genuity | Buy |
| 2019-09-23 | 개시 | Piper Jaffray | Overweight |
| 2019-07-24 | 재확인 | BofA/Merrill | Buy |
| 2019-03-18 | 재확인 | Canaccord Genuity | Buy |
| 2019-01-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Hold |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-10-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
모두보기
에드워즈라이프사이언시스 주식(EW)의 최신 뉴스
Intech Investment Management LLC Has $5.91 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Insider Sell: Andrew Dahl Sells Shares of Edwards Lifesciences C - GuruFocus
Geode Capital Management LLC Trims Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Andrew Dahl Sells 568 Shares of Edwards Lifesciences (NYSE:EW) Stock - MarketBeat
Edwards Lifesciences (EW) SVP records small open-market stock sale - Stock Titan
Edwards Lifesciences (NYSE: EW) affiliate reports two 13,000-share sales - Stock Titan
Edwards Lifesciences (NYSE: EW) files Form 144 for proposed common sale - Stock Titan
Boston Scientific’s $1.5B bet signals heart valve market battle - Modern Healthcare
Edwards Lifesciences Corp. Hits New 52-Week High at USD 88.25 - Markets Mojo
Edwards Lifesciences Corp. Hits New 52-Week High at USD 87.93 - Markets Mojo
Allstate Corp Grows Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Is Edwards Lifesciences (EW) Fairly Priced After Recent Share Price Strength? - Yahoo Finance
Edwards Lifesciences CVP Donald Bobo Jr. sells $2m in stock - Investing.com UK
Edwards Lifesciences CVP Donald Bobo Jr. sells $2m in stock By Investing.com - Investing.com Australia
Edwards Lifesciences (EW) executive sells 23,145 shares at $86.42 average price - Stock Titan
Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Donald Bobo reports multiple Common stock sales (EW) in Form 144 - Stock Titan
Edwards Lifesciences Has Everything Investors Want Except Value (NYSE:EW) - Seeking Alpha
Legal & General Group Plc Has $376.46 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Edwards Lifesciences stock hits 52-week high at 87.89 USD - Investing.com
Swedbank AB Lowers Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences’ SWOT analysis: stock gains from rival’s setback By Investing.com - Investing.com Australia
Edwards Lifesciences’ SWOT analysis: stock gains from rival’s setback - Investing.com
Edwards Lifesciences Corp. (EW) Stock Analysis: Healthcare Giant with 13% Upside Potential - DirectorsTalk Interviews
Edwards Lifesciences Corporation (NYSE:EW) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Rathbones Group PLC - MarketBeat
ABN Amro Investment Solutions Raises Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
EW Price History for Edwards Lifesciences Corp Stock - Barchart.com
Insider Sell Alert: Daveen Chopra Sells Shares of Edwards Lifesc - GuruFocus
Analysts Offer Insights on Healthcare Companies: P3 Health Partners (PIII) and Edwards Lifesciences (EW) - The Globe and Mail
Edwards Lifesciences Corp (EW) Stock Up 3.1% and Still Undervalued -- GF Score: 95/100 - GuruFocus
Edwards Lifesciences (NYSE: EW) exec sells 1,500 common shares - Stock Titan
Edwards Lifesciences (EW) Form 144: Broker-listed proposed sale notice - Stock Titan
19,073 Shares in Edwards Lifesciences Corporation $EW Purchased by Fideuram Intesa Sanpaolo Private Banking S.P.A. - MarketBeat
Investment House LLC Trims Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
North Dakota State Investment Board Buys Shares of 19,728 Edwards Lifesciences Corporation $EW - MarketBeat
Handelsbanken Fonder AB Has $102.60 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences CVP Lippis sells $50,306 of common stock By Investing.com - Investing.com Nigeria
Insider Sell Alert: Daniel Lippis Sells Shares of Edwards Lifesc - GuruFocus
Edwards Lifesciences (NYSE:EW) VP Sells $50,306.80 in Stock - MarketBeat
Edwards Lifesciences CVP Lippis sells $50,306 of common stock - Investing.com India
Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M - TradingView
Edwards Lifesciences exec sells 620 shares after option exercise | EW Insider Trading - Stock Titan
Edwards Lifesciences (EW) CVP Donald Bobo Jr. sells 17,968 shares in open-market trades - Stock Titan
Edwards Lifesciences Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Edwards Lifesciences (NYSE: EW) Form 144 lists 150,758 units via broker - Stock Titan
Northwestern Mutual Wealth Management Co. Purchases 1,093,692 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
[144] Edwards Lifesciences Corp SEC Filing - Stock Titan
Edwards Lifesciences Corporation $EW Stock Position Boosted by Bank Julius Baer & Co. Ltd Zurich - MarketBeat
Are Wall Street Analysts Bullish on Edwards Lifesciences Stock? - Yahoo Finance
에드워즈라이프사이언시스 (EW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.94%
0.83%
자본화:
|
볼륨(24시간):